Jane E. Schupp
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Cancer-related Molecular Pathways
Papers in
-
- DNA Repair Mechanisms 15
- CRISPR and Genetic Engineering 2
-
- Cancer Genomics and Diagnostics 5
- Cancer, Hypoxia, and Metabolism 4
- Carcinogens and Genotoxicity Assessment 2
- Co-authors
- Timothy J. Kinsella (17 shared papers)Tao Yan (6 shared papers)Yuji Seo (6 shared papers)Stanton L. Gerson (3 shared papers)Omer N. Koç (2 shared papers)Keunmyoung Lee (2 shared papers)Xuehuo Zeng (2 shared papers)Brian M. Davis (1 shared paper)
- Journals
- Cancer Research (4 papers)Clinical Cancer Research (3 papers)Nature Communications (1 paper)Molecular Cancer Therapeutics (1 paper)ACS Chemical Neuroscience (1 paper)
- Partner nations
- United States
In The Last Decade
Jane E. Schupp
25 papers receiving 722 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 155
- Oncology 208
- Pathology and Forensic Medicine 131
- Molecular Biology 535
- Genetics 39
Countries citing papers authored by Jane E. Schupp
This map shows the geographic impact of Jane E. Schupp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane E. Schupp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane E. Schupp more than expected).
Fields of papers citing papers by Jane E. Schupp
This network shows the impact of papers produced by Jane E. Schupp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane E. Schupp. The network helps show where Jane E. Schupp may publish in the future.
Co-authors
The 25 scholars most cited alongside Jane E. Schupp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 107 | |
| 2 | Selection for G156A O6-methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and protection from lethality in mice treated with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea. | 1997 | 100 |
| 3 | 2007 | 68 | |
| 4 | Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization. | 2003 | 66 |
| 5 | Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation. | 2001 | 62 |
| 6 | 2006 | 48 | |
| 7 | 2015 | 45 | |
| 8 | Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine. | 2000 | 39 |
| 9 | 2006 | 27 | |
| 10 | 2004 | 26 | |
| 11 | 2007 | 26 | |
| 12 | Preclinical study of the systemic toxicity and pharmacokinetics of 5-iodo-2-deoxypyrimidinone-2'-deoxyribose as a radiosensitizing prodrug in two, non-rodent animal species: implications for phase I study design. | 2000 | 20 |
| 13 | Preclinical toxicity and efficacy study of a 14-day schedule of oral 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine radiosensitization in U251 human glioblastoma xenografts. | 2000 | 20 |
| 14 | 2006 | 12 | |
| 15 | Differential degradation rates of inactivated alkyltransferase in blood mononuclear cells and tumors of patients after treatment with O(6)-benzylguanine. | 2001 | 12 |
| 16 | Heterogeneity of O6-alkylguanine-DNA-alkyltransferase measured by flow cytometric analysis in blood and bone marrow mononuclear cells. | 1998 | 11 |
| 17 | 2009 | 10 | |
| 18 | 2019 | 10 | |
| 19 | 2005 | 9 | |
| 20 | 2007 | 7 |
About Jane E. Schupp
Jane E. Schupp is a scholar working on Molecular Biology, Cancer Research, Pathology and Forensic Medicine, Oncology and Genetics, having authored 25 papers that have together received 737 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (15 papers), Genetic factors in colorectal cancer (9 papers), Cancer Genomics and Diagnostics (5 papers), Cancer-related Molecular Pathways (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Carcinogens and Genotoxicity Assessment (2 papers), Glioma Diagnosis and Treatment (2 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Cancer Research (155 citations), Oncology (208 citations), Pathology and Forensic Medicine (131 citations), Molecular Biology (535 citations) and Genetics (39 citations). Jane E. Schupp has collaborated with scholars based in United States. Frequent co-authors include Timothy J. Kinsella, Tao Yan, Yuji Seo, Stanton L. Gerson, Omer N. Koç, Keunmyoung Lee, Xuehuo Zeng, Brian M. Davis, Jane Reese and Sanjeev Kumar. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Nature Communications, Molecular Cancer Therapeutics and ACS Chemical Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.